Antibody–drug conjugates targeting HER2-mutant or HER2-(non) amplified solid tumors: is HER2 an agnostic target?
- Resource Type
- Article
- Source
- Expert Opinion on Biological Therapy; November 2023, Vol. 23 Issue: 11 p1039-1042, 4p
- Subject
- Language
- ISSN
- 14712598; 17447682